OBJECTIVE Allergic bronchopulmonary aspergillosis (ABPA) occurs in cases of atopic asthma and may result in important lung disease. Early diagnosis is essential as this disease is responsive to steroids. However, while asthma is common, ABPA is infrequently diagnosed. CT allows precision in the diagnosis of central bronchiectasis (which is virtually pathognomonic of ABPA) and may enable earlier...

BACKGROUND AND OBJECTIVE The prevalence of allergic bronchopulmonary aspergillosis (ABPA) in patients with bronchial asthma remains unknown. We evaluated the roles of various laboratory tests in the diagnosis of ABPA, including, skin prick test (SPT) for Aspergillus fumigatus (Af), and serum Af specific IgE and IgG antibody measurement. METHODS A total of 50 asthma patients with more than 100...

BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is a complex condition that affects people with asthma and cystic fibrosis (CF). It results from exposure to the fungus Aspergillus fumigatus, which leads to worsening airway inflammation and progressive damage to the lungs. The aim of this review is to outline the pathogenesis of the disorder, diagnostic criteria and to discuss the use ...

Allergic bronchopulmonary aspergillosis (ABPA) is infrequently documented in children with asthma. Although collapse is not uncommon, middle lobe syndrome (MLS) as a presentation of ABPA is rather a rarity. A 9-year-old female child with asthma presented with increase in intensity of symptoms along with a right midzone patchy consolidation on a chest radiograph. In addition, an ill-defined opac...

BACKGROUND Aspergillus fumigatus, a widely distributed fungus, has been implicated in causing life threatening infections as well as severe asthma and allergic diseases in man. Allergic affliction like allergic bronchopulmonary aspergillosis (ABPA) is a disabling lung disease frequently seen in patients with asthma and cystic fibrosis. Immunodiagnosis of the former is comparatively easier due t...

TO THE EDITOR—We read with great interest the brief report of a case of allergic bronchopulmonary aspergillosis (ABPA) in a human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)-infected patient on combined antiretroviral therapy (cART) by Galiatsatos et al [1]. Allergic bronchopulmonary aspergillosis usually complicates lung disease in patients affected by cystic fibros...

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitive disease showing various radiographic and clinical manifestations. Its clinical course has not been fully understood. Here I describe a case of a 23-year-old immunocompetent man with frequently relapsing ABPA. He was asthmatic. He visited our hospital because of a chronic cough. Laboratory examination showed eosinophilia with inc...

Allergic bronchopulmonary aspergillosis (ABPA) is a disease induced by an exaggerated immune response to Aspergillus fumigatus, often occurring in susceptible adult patients with asthma and cystic fibrosis (CF). Proper treatments can alleviate symptoms, reduce pulmonary infiltrates and prevent progression of lung destruction. However, treatment experiences in ABPA children without CF are limite...

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to the fungus Aspergillus fumigatus, causing severe asthma that may progress to bronchiectasis. Sputum neutrophilia can occur in association with sputum eosinophilia and correlates with the degree of bronchiectasis. The mechanisms of sputum neutrophilia in ABPA are not known. The aim of this study was to investigate t...

Fungal spores are ubiquitously present in the air. Inhalation of these spores by humans causes disease in susceptible patients; most prevalent are invasive aspergillosis and allergic bronchopulmonary aspergillosis (ABPA). This chapter provides an overview of the pathogenecity, clinical appearance, diagnosis and treatment of ABPA. ABPA is a hypersensitivity lung disease limited to patients with ...